Completed
Single Dose Pharmacokinetic (PK) Study
NCT03109756
- Conditions
- Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +15 more
- Locations
-
- Ovid Therapeutics Investigative Site Chicago, Illinois, United States
- Ovid Therapeutics Investigative Site Nashville, Tennessee, United States